118 related articles for article (PubMed ID: 16362297)
1. Enforced expression of cytosolic 5'-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection.
Gray T; Morrey EL; Gangadharan B; Sumter TF; Spychala J; Archer DR; Spencer HT
Cancer Chemother Pharmacol; 2006 Jul; 58(1):117-28. PubMed ID: 16362297
[TBL] [Abstract][Full Text] [Related]
2. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
Nivens MC; Felder T; Galloway AH; Pena MM; Pouliot JJ; Spencer HT
Cancer Chemother Pharmacol; 2004 Feb; 53(2):107-15. PubMed ID: 14605862
[TBL] [Abstract][Full Text] [Related]
3. Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells.
Takebe N; Zhao SC; Ural AU; Johnson MR; Banerjee D; Diasio RB; Bertino JR
Cancer Gene Ther; 2001 Dec; 8(12):966-73. PubMed ID: 11781659
[TBL] [Abstract][Full Text] [Related]
4. Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase.
Belzile JP; Karatzas A; Shiu HY; Létourneau S; Palerme JS; Cournoyer D
Cancer Gene Ther; 2003 Aug; 10(8):637-46. PubMed ID: 12872145
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Fluorouracil-inducible GM-CSF gene therapy regulated by Egr-1 promoter on chemotherapeutic hematopoietic damage of tumor-bearing mice].
Du N; Pei XT; Xiao WH; Sun JZ; Fu Y; Zhao H; Wang XL
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1281-6. PubMed ID: 19595187
[TBL] [Abstract][Full Text] [Related]
6. Secretory lysosome targeting and induced secretion of human soluble TNF-alpha receptor in murine hematopoietic cells in vivo as a principle for immunoregulation in inflammation and malignancy.
Johansson AC; Nandakumar KS; Persson AM; Olsson I; Hansson M
Exp Hematol; 2009 Aug; 37(8):969-78. PubMed ID: 19486922
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.
Jordheim LP; Marton Z; Rhimi M; Cros-Perrial E; Lionne C; Peyrottes S; Dumontet C; Aghajari N; Chaloin L
Biochem Pharmacol; 2013 Feb; 85(4):497-506. PubMed ID: 23220537
[TBL] [Abstract][Full Text] [Related]
8. Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells.
Wang Z; Song J; Taichman RS; Krebsbach PH
Stem Cells; 2006 Jun; 24(6):1573-82. PubMed ID: 16769762
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of pigeon breast muscle cytosolic 5'-nucleotidase-I (cN-I).
Tkacz-Stachowska K; Lechward K; Skladanowski AC
Acta Biochim Pol; 2005; 52(4):789-96. PubMed ID: 15940349
[TBL] [Abstract][Full Text] [Related]
10. Induction of human high K(M) 5'-nucleotidase in cultured 293 cells.
Gazziola C; Moras M; Ferraro P; Gallinaro L; Verin R; Rampazzo C; Reichard P; Bianchi V
Exp Cell Res; 1999 Dec; 253(2):474-82. PubMed ID: 10585270
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
13. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
14. What does over-expression of cN-II enzyme signify in haematological malignancies?
Galmarini CM
Leuk Res; 2007 Oct; 31(10):1325-6. PubMed ID: 17434583
[No Abstract] [Full Text] [Related]
15. Initial studies to define the physiologic role of cN-II.
Filoni DN; Pesi R; Careddu MG; Camici M; Allegrini S; Collavoli A; Scarfone I; Zucchi F; Galli A; Tozzi MG
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1155-60. PubMed ID: 22132970
[TBL] [Abstract][Full Text] [Related]
16. Stably transfected adherent cancer cell models with decreased expression of 5'-nucleotidase cN-II.
Bricard G; Cros-Perrial E; Machon C; Dumontet C; Jordheim LP
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):604-612. PubMed ID: 27906612
[TBL] [Abstract][Full Text] [Related]
17. Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle.
Hanisch F; Hellsten Y; Zierz S
Biol Chem; 2006 Jan; 387(1):53-8. PubMed ID: 16497164
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
Reese JS; Roth JC; Gerson SL
Stem Cells; 2008 Mar; 26(3):675-81. PubMed ID: 18192231
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells.
Cai S; Hartwell JR; Cooper RJ; Juliar BE; Kreklau E; Abonour R; Goebel WS; Pollok KE
Mol Ther; 2006 May; 13(5):1016-26. PubMed ID: 16426896
[TBL] [Abstract][Full Text] [Related]
20. Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow.
Das JR; Fryar-Tita EB; Green S; Southerland WM; Bowen D
Anticancer Res; 2007; 27(2):825-33. PubMed ID: 17465208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
